Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/11879
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDivyang, Makwana-
dc.date.accessioned2023-08-17T10:29:51Z-
dc.date.available2023-08-17T10:29:51Z-
dc.date.issued2023-06-01-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/11879-
dc.description.abstractA malignant brain tumor known as a glioblastoma is an extremely life-threatening condition. It has been demonstrated that a favorable risk factor and indication of how well patients respond to chemotherapy is the presence of a specific genetic sequence known as MGMT promoter methylation in tumors. The only way to determine the presence of MGMT promoters so far is through genetic analyses that require an operation. In order to reduce the number of operations, it would be helpful to develop an accurate method for determining the presence of MGMT promoters using only MRI.en_US
dc.publisherInstitute of Technologyen_US
dc.relation.ispartofseries21MCEC15;-
dc.subjectComputer 2021en_US
dc.subjectProject Report 2021en_US
dc.subjectComputer Project Reporten_US
dc.subjectProject Reporten_US
dc.subject21MCEen_US
dc.subject21MCECen_US
dc.subject21MCEC15en_US
dc.titleMGMT Classification in MRI Imagesen_US
dc.typeDissertationen_US
Appears in Collections:Dissertation, CE

Files in This Item:
File Description SizeFormat 
21MCEC15.pdf21MCEC151.1 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.